AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27

Authors: Hiatt, WR
Citation: Wr. Hiatt, New treatment options in intermittent claudication: the US experience, INT J CL PR, 2001, pp. 20-27

Authors: Mehler, PS Scott, JY Pines, I Gifford, N Biggerstaff, S Hiatt, WR
Citation: Ps. Mehler et al., Russian immigrant cardiovascular risk assessment, J HEAL C P, 12(2), 2001, pp. 224-235

Authors: Seals, DR Tanaka, H Clevenger, CM Monahan, KD Reiling, MJ Hiatt, WR Davy, KP DeSouza, CA
Citation: Dr. Seals et al., Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: Role of arterial stiffness, J AM COL C, 38(2), 2001, pp. 506-513

Authors: Brass, EP Hiatt, WR Gardner, AW Hoppel, CL
Citation: Ep. Brass et al., Decreased NADH dehydrogenase and ubiquinol-cytochrome c oxidoreductase in peripheral arterial disease, AM J P-HEAR, 280(2), 2001, pp. H603-H609

Authors: Brass, EP Adler, S Sietsema, KE Hiatt, WR Orlando, AM Amato, A
Citation: Ep. Brass et al., Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients, AM J KIDNEY, 37(5), 2001, pp. 1018-1028

Authors: Hirsch, AT Criqui, MH Treat-Jacobson, D Regensteiner, JG Creager, MA Olin, JW Krook, SH Hunninghake, DB Comerota, AJ Walsh, ME McDermott, MM Hiatt, WR
Citation: At. Hirsch et al., Peripheral arterial disease detection, awareness, and treatment in primarycare, J AM MED A, 286(11), 2001, pp. 1317-1324

Authors: Hiatt, WR
Citation: Wr. Hiatt, Drug therapy - Medical treatment of peripheral arterial disease and claudication., N ENG J MED, 344(21), 2001, pp. 1608-1621

Authors: Hiatt, WR Regensteiner, JG Creager, MA Hirsch, AT Cooke, JP Olin, JW Gorbunov, GN Isner, J Lukjanov, YV Tsitsiashvili, MS Zabelskaya, TF Amato, A
Citation: Wr. Hiatt et al., Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication, AM J MED, 110(8), 2001, pp. 616-622

Authors: Lederman, RJ Tenaglia, AN Anderson, RD Hermiller, JB Rocha-Singh, K Mendelsohn, FO Hiatt, WR Moon, T Whitehouse, MJ Annex, BH
Citation: Rj. Lederman et al., Design of The Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 for Intermittent Claudication (TRAFFIC) trial, AM J CARD, 88(2), 2001, pp. 192

Authors: Jaff, MR Hiatt, WR
Citation: Mr. Jaff et Wr. Hiatt, Clinical and vascular laboratory evaluation of peripheral arterial disease, PERIPHERAL ARTERIAL DISEASE HANDBOOK, 2001, pp. 81-94

Authors: Brass, EP Wang, H Hiatt, WR
Citation: Ep. Brass et al., Multiple skeletal muscle mitochondrial DNA deletions in patients with unilateral peripheral arterial disease, VASC MED, 5(4), 2000, pp. 225-230

Authors: Krupski, WC Nehler, MR Whitehill, TA Lawson, RC Strecker, PK Hiatt, WR
Citation: Wc. Krupski et al., Negative impact of cardiac evaluation before vascular surgery, VASC MED, 5(1), 2000, pp. 3-9

Authors: Brass, EP Hiatt, WR
Citation: Ep. Brass et Wr. Hiatt, Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease, VASC MED, 5(1), 2000, pp. 55-59

Authors: McDaniel, MD Nehler, MR Santilli, SM Hiatt, WR Regensteiner, JG Goldstone, J McCarthy, WJ White, JV
Citation: Md. Mcdaniel et al., Extended outcome assessment in the care of vascular diseases: Revising theparadigm for the 21st century, J VASC SURG, 32(6), 2000, pp. 1239-1250

Authors: Hiatt, WR
Citation: Wr. Hiatt, Regarding: "Expression of myosin heavy chain isoforms in skeletal muscle of patients with peripheral arterial occlusive disease", J VASC SURG, 31(3), 2000, pp. 611-612

Authors: Dawson, DL Cutler, BS Hiatt, WR Hobson, RW Martin, JD Bortey, EB Forbes, WP Strandness, DE
Citation: Dl. Dawson et al., A comparison of cilostazol and pentoxifylline for treating intermittent claudication, AM J MED, 109(7), 2000, pp. 523-530

Authors: Bauer, TA Regensteiner, JG Brass, EP Hiatt, WR
Citation: Ta. Bauer et al., Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease, J APP PHYSL, 87(2), 1999, pp. 809-816

Authors: Labs, KH Nehler, MR Roessner, M Jaeger, KA Hiatt, WR
Citation: Kh. Labs et al., Reliability of treadmill testing in peripheral arterial disease: a comparison of a constant load with a graded load treadmill protocol, VASC MED, 4(4), 1999, pp. 239-246

Authors: Labs, KH Dormandy, JA Jaeger, KA Stuerzebecher, CS Hiatt, WR
Citation: Kh. Labs et al., Trans-Atlantic conference on clinical trial guidelines in PAOD (peripheralarterial occlusive disease) clinical trial methodology, EUR J VAS E, 18(3), 1999, pp. 253-265

Authors: Nehler, MR Hiatt, WR
Citation: Mr. Nehler et Wr. Hiatt, Exercise therapy for claudication, ANN VASC S, 13(1), 1999, pp. 109-114

Authors: Nehler, MR Whitehill, TA Bowers, SP Jones, DN Hiatt, WR Rutherford, RB Krupski, WC
Citation: Mr. Nehler et al., Intermediate-term outcome of primary digit amputations in patients with diabetes mellitus who have forefoot sepsis requiring hospitalization and presumed adequate circulatory status, J VASC SURG, 30(3), 1999, pp. 509-517

Authors: Wang, H Hiatt, WR Barstow, TJ Brass, EP
Citation: H. Wang et al., Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: alterations with disease, EUR J A PHY, 80(1), 1999, pp. 22-27

Authors: Brandenburg, SL Reusch, JEB Bauer, TA Jeffers, BW Hiatt, WR Regensteiner, JG
Citation: Sl. Brandenburg et al., Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes, DIABET CARE, 22(10), 1999, pp. 1640-1646

Authors: Bhat, HK Hiatt, WR Hoppel, CL Brass, EP
Citation: Hk. Bhat et al., Skeletal muscle mitochondrial DNA injury in patients with unilateral peripheral arterial disease, CIRCULATION, 99(6), 1999, pp. 807-812

Authors: Dawson, DL Beebe, HG Davidson, MH Chinoy, DA Herd, JA Hiatt, WR Heckman, JD Bortey, EB Forbes, WP
Citation: Dl. Dawson et al., Cilostazol or pentoxifylline for claudication? (vol 98, pg 58, 1998), CIRCULATION, 99(2), 1999, pp. 328-328
Risultati: 1-25 | 26-27